Pathogenesis of rheumatoid arthritis

Journal of the Korean Medical Association

Volumn 53, Issue 10, 2010, Pages 853-861

  Kim, Ji Min ^a   Kim, Ho Youn ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Pathogenesis; Rheumatoid arthritis; Therapeutic target

Indexed keywords

EID: 78149449600     PISSN: 19758456     EISSN: None     Source Type: Journal    
DOI: 10.5124/jkma.2010.53.10.853     Document Type: Article

References (19)

1. Leipe J, Grunke M, Dechant C, Reindl C, Kerzendorf U, SchuIze-Koops H, Skapenko A. Role of Th17 cells in autoimmune arthritis. Arthritis Rheum 2010; 62:2876-2885.
2. Furuzawa-Carballeda J, Vargas-Rojas Ml, Cabral AR. Autoimmune inflammation from the Th17 perspective. Autoimmun Rev 2007; 6:169-175.
3. Nistala K, Moncrieffe H, Newton KR, Varsani H, Hunter P, Wedderburn LR. lnterleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers. Arthritis Rheum 2008; 58:875-887.
4. Kim HY, Kim WU, Cho ML, Lee SK, Youn J, Kim SI, Yoo WH, Park JH, Min JK, Lee SH, Park SH, Cho CS. Enhanced T cell proliferative response to type Il collagen and synthetic peptide CII (255-274) in patients with rheumatoid arthritis. Arthritis Rheum 1999; 42:2085-2093.
5. Park SH, Min DJ, Cho ML, Kim WU, Youn J, Park W, Cho CS, Kim HY. Shift toward T helper 1 cytokines by type Il collagenreactive T cells in patients with rheumatoid arthritis. Arthritis Rheum 2001; 44: 561-569.
6. Cho ML, Yoon CH, Hwang SY, Park MK, Mm SY, Lee SH, Park SH, Kim HY. Effector function of type II collagen-stimulated T cells from rheumatoid arthritis patients: cross-talk between T cells and synovial fibroblasts. Arthritis Rheum 2004; 50:776-784.
7. Mm DJ, Cho ML, Lee SH, Min SY, Kim WU, Mm JK, Park SH, Cho CS, Kim HY. Augmented production of chemokines by the interaction of type Il collagen-reactive T cells with rheumatoid synovial fibroblasts. Arthritis Rheum 2004; 50: 1146-1155.
8. De Rycke L, Nicholas AP, Cantaert T, Kruithof E, Echols JD, Vandekerckhove B, Veys EM, De Keyser F, Baeten D. Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deiminase as pathophysiologically relevant antigenic determinants of rheumatoid arthritis-specific humoral autoimmunity. Arthritis Rheum 2005; 52: 2323-2330.
9. Chang X, Yamada R, Suzuki A Sawada T, Yoshino S, Tokuhiro S, Yamamoto K. Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis. Rheumatology (Oxford) 2005; 44:40-50.
10. Cho ML, Kang JW, Moon YM, Nam HJ, Jhun JY, Heo SB, Jin HT, Min SY, Ju JH, Park KS, Cho YG, Yoon CH, Park SH, Sung YC, Kim HY. STAT3 and NF-kappaB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-I receptor antagonist-deficient mice. J Immunol 2006; 176: 5652-5661.
11. Kim HR, Cho ML, Kim KW, Juhn JY, Hwang SY, Yoon CH, Park SH, Lee SH, Kim HY. Up-regulation of IL-23p19 expression in rheumatoid arthritis synovial fibroblasts by IL-17 through PI3-kinase-, NF-kappaB- and p38 MAPK-dependent signalling pathways. Rheumatology (Oxford) 2007; 46: 57-64.
12. Edwards JC, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close DR, Stevens RM, Shaw T. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 2004; 350: 2572-2581.
13. Emery P, Fleischmann R, Filipowicz-Sosnowska A, Schechtman J, Szczepanski L, Kavanaugh A, Racewicz AJ, van Vollenhoven RF, Li NF, Agarwal S, Hessey EW, Shaw TM. The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase NB randomized, double-blind, placebo-controlled, dose-ranging trial. Arthritis Rheum 2006; 54:1390-1400.
14. Cush JJ, Splawski JB, Thomas R, McFarlin JE, Schulze-Koops H, Davis LS, Fujita K, Lipsky PE. Elevated interleukin-10 levels in patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 96-104.
15. He X, Goronzy JJ, Weyand CM. The repertoire of rheumatoid factor-producing B cells in normal subjects and patients with rheumatoid arthritis. Arthritis Rheum 1993; 36:1061-1069.
16. Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH. Rheumatology. 4 ed: MOSBY, 2007:811-866.
17. Mclnnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 2007; 7:429-442.
18. Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 2000; 106:1481-1488.
19. Kim KW, Cho ML, Lee SH, Oh HJ, Kang CM, Ju JH, Mm SY, Cho YG, Park SH, Kim HY. Human rheumatoid synovial fibroblasts promote osteoclastogenic activity by activating RANKL via TLR-2 and TLR4 activation. Immunol Lett 2007; 110: 54-64.